Neoadjuvant Sorafenib Treatment of Clear Cell Renal Cell Carcinoma and Release of Circulating Tumor Fragments()

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is characterized by high constitutive vascular endothelial growth factor A (VEGF-A) production that induces a specific vascular phenotype. We previously reported that this phenotype may allow shedding of multicellular tumor fragments into the circu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kats-Ugurlu, Gursah, Oosterwijk, Egbert, Muselaers, Stijn, Oosterwijk-Wakka, Jeannette, Hulsbergen-van de Kaa, Christina, de Weijert, Mirjam, van Krieken, Han, Desar, Ingrid, van Herpen, Carla, Maass, Cathy, de Waal, Rob, Mulders, Peter, Leenders, William
Formato: Artigo
Idioma:Inglês
Publicado em: Neoplasia Press 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4094826/
https://ncbi.nlm.nih.gov/pubmed/24726142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2014.03.007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados